Regulatory & Quality Due Diligence
BioVision performs independent regulatory and quality due diligence audits for the management, board members, and investors of medical device companies. Before an acquisition, investment, or major decision, we give you a clear, objective picture of a company's regulatory standing and the risks and costs hidden in it.
What our due diligence reveals
-
The true status and validity of existing approvals (FDA clearances, CE marks).
-
Gaps in the quality system that could threaten compliance.
-
Outstanding regulatory obligations and their cost to resolve.
-
Risks in clinical evidence, cybersecurity, or AI compliance.
-
A realistic timeline and budget to reach or maintain market access.
How BioVision helps
-
Independent regulatory and quality audits
-
Risk and gap assessment with cost estimates
-
Clear, decision-ready reporting for boards and investors
Frequently Asked Questions
Why is regulatory due diligence important before an investment?
A device company's value depends heavily on the validity of its approvals and the strength of its quality system. Hidden gaps can mean large remediation costs or lost market access - exactly what due diligence uncovers.
Who uses BioVision's due diligence services?
Investors, acquirers, boards, and management teams who need an independent, expert assessment before making high-stakes decisions.